Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer.

Tilman D RachnerSabine Kasimir-BauerAndy GöbelKati ErdmannOliver HoffmannAndrew BrownePauline WimbergerMartina RaunerLorenz C HofbauerRainer KimmigAnn-Kathrin Bittner

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2018)

These findings warrant further investigation as they provide a rationale for novel diagnostic or therapeutic approaches.

Keyphrases

clinical trial
nuclear factor
toll like receptor
young adults
breast cancer risk